We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 11.00 | 1.13% | 986.00 | 967.00 | 985.00 | 988.00 | 968.00 | 988.00 | 90,790 | 16:29:58 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Unit Inv Tr, Closed-end Mgmt | -32.42M | -41.3M | -1.0034 | -9.77 | 403.36M |
From Feb 2024 to May 2024
PR Newswire
LONDON, United Kingdom, February 27
BLOCK LISTING SIX MONTHLY RETURN
Date: 27 February 2024
| Name of applicant: | The Biotech Growth Trust PLC | |||
| Name of scheme: | General | |||
| Period of return: | From: | 27 August 2023 | To: | 26 February 2024 |
| Balance of unallotted securities under scheme(s) from previous return: | 3,530,634 | |||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
| Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | Nil | |||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 3,530,634 | |||
| Name of contact: | Katherine Manson - Frostrow Capital LLP |
| Telephone number of contact: | 020 3709 8734 |
1 Year Biotech Growth Chart |
1 Month Biotech Growth Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
